跳至主要内容
临床试验/NCT03245944
NCT03245944已完成不适用

Optimal Timing of Percutaneous Intervention in Non-maturing Dialysis Fistulas

University of Alabama at Birmingham2 个研究点 分布在 1 个国家目标入组 8 人开始时间: 2018年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
8
试验地点
2
主要终点
Fistula Maturity

研究概览

简要总结

Arteriovenous fistulas (AVFs) are the preferred type of vascular access for dialysis, but many of them fail to mature. The optimal timing of intervention to salvage immature AVFs is unknown.The study proposes a randomized clinical trial comparing the clinical and economic impact of early vs late angioplasty in non-maturing AVFs.

The study proposes a RCT to test the hypothesis that, as compared to early angioplasty of non-maturing AVFs, late angioplasty results in a lower proportion of AVFs being used at 6 months, but a greater long-term AVF patency , lower requirement of subsequent interventions to maintain AVF patency for dialysis, and lower overall cost of access maintenance.

详细描述

The optimal timing of intervention in non-maturing AVFs remains controversial, and can only be definitively addressed by a randomized clinical trial (RCT) comparing early (6 weeks) vs late (3 months) angioplasty of non-maturing AVFs. The investigators will perform a single-center, prospective RCT. The investigators will recruit 112 patients who initiated hemodialysis with a CVC, then had a new AVF created after commencing dialysis, and then had a 6-week postoperative ultrasound that revealed an immature AVF (diameter < 4 mm diameter or blood flow < 500 ml/min). These patients will be randomized to one of two groups: an early intervention group that will undergo a routine PTA at 6 weeks after AVF creation, or a late intervention group in which early PTA will be avoided and subsequently be performed only if the 3-month ultrasound indicates persistent AVF immaturity. These patients will be followed for 2 years.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with End stage renal disease (ESRD).
  • Patients on hemodialysis.
  • Patients using central venous catheter (CVC).
  • Patients who had a new AVF created after commencing dialysis.
  • Patients who had immature fistula ( 6-week postoperative ultrasound that revealed an immature AVF (diameter < 4 mm diameter or blood flow < 500 ml/min).

排除标准

  • Children with Age below 18

结局指标

主要结局

Fistula Maturity

时间窗: baseline- 6 months

Ultrasound of the fistula: Mature fistula Criteria: 1. Blood flow of at least 500 ml/min and 2. Minimum diameter of 4 mm

次要结局

  • Fistula survival(baseline-2 years)
  • Fistula adequacy(Baseline- 2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Alian Al-Balas

Prinicipal investigator

University of Alabama at Birmingham

研究点 (2)

Loading locations...

相似试验